Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial - Hirschberg, AL; Sánchez-Rovira, P; Presa-Lorite, J (Menopause, 2020)
et al.